• Je něco špatně v tomto záznamu ?

Impact of antiphospholipid syndrome on placenta and uterine NK cell function: insights from a mouse model

A. Martirosyan, E. Kriegova, J. Savara, L. Abroyan, S. Ghonyan, Z. Slobodova, R. Nesnadna, G. Manukyan

. 2024 ; 14 (1) : 31163. [pub] 20241228

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002962

Grantová podpora
FNOl, 00098892 MH CZ - DRO
UP_2024_013. IGA LF
SCS 21AG-1F072 State Committee Science MES RA

Antiphospholipid syndrome (APS) is associated with recurrent pregnancy morbidity, yet the underlying mechanisms remain elusive. We performed multifaceted characterization of the biological and transcriptomic signatures of mouse placenta and uterine natural killer (uNK) cells in APS. Histological analysis of APS placentas unveiled placental abnormalities, including disturbed angiogenesis, occasional necrotic areas, fibrin deposition, and nucleated red blood cell enrichment. Analyses of APS placentas showed a reduced cell proliferation, lower protein content and thinning of endothelial cells. Disturbances in APS trophoblast cells were linked to a cell cycle shift in cytotrophoblast cells, and a reduced number of spiral artery-associated trophoblast giant cells (SpA-TGC). Transcriptomic profiling of placental tissue highlighted disruptions in cell cycle regulation with notable downregulation of genes involved in developmental or signaling processes. Cellular senescence, metabolic and p53-related pathways were also enriched, suggesting potential mechanisms underlying placental dysfunction in APS. Thrombotic events, though occasionally detected, appeared to have no significant impact on the overall pathological changes. The increased number of dysfunctional uNK cells was not associated with enhanced cytotoxic capabilities. Transcriptomic data corroborated these findings, showing prominent suppression of NK cell secretory capacity and cytokine signaling pathways. Our study highlights the multifactorial nature of APS-associated placental pathologies, which involve disrupted angiogenesis, cell cycle regulation, and NK cell functionality.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002962
003      
CZ-PrNML
005      
20250206103958.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-024-82451-2 $2 doi
035    __
$a (PubMed)39732740
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Martirosyan, A $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Biology NAS RA, 7 Hasratyan Str., Yerevan, 0014, Armenia
245    10
$a Impact of antiphospholipid syndrome on placenta and uterine NK cell function: insights from a mouse model / $c A. Martirosyan, E. Kriegova, J. Savara, L. Abroyan, S. Ghonyan, Z. Slobodova, R. Nesnadna, G. Manukyan
520    9_
$a Antiphospholipid syndrome (APS) is associated with recurrent pregnancy morbidity, yet the underlying mechanisms remain elusive. We performed multifaceted characterization of the biological and transcriptomic signatures of mouse placenta and uterine natural killer (uNK) cells in APS. Histological analysis of APS placentas unveiled placental abnormalities, including disturbed angiogenesis, occasional necrotic areas, fibrin deposition, and nucleated red blood cell enrichment. Analyses of APS placentas showed a reduced cell proliferation, lower protein content and thinning of endothelial cells. Disturbances in APS trophoblast cells were linked to a cell cycle shift in cytotrophoblast cells, and a reduced number of spiral artery-associated trophoblast giant cells (SpA-TGC). Transcriptomic profiling of placental tissue highlighted disruptions in cell cycle regulation with notable downregulation of genes involved in developmental or signaling processes. Cellular senescence, metabolic and p53-related pathways were also enriched, suggesting potential mechanisms underlying placental dysfunction in APS. Thrombotic events, though occasionally detected, appeared to have no significant impact on the overall pathological changes. The increased number of dysfunctional uNK cells was not associated with enhanced cytotoxic capabilities. Transcriptomic data corroborated these findings, showing prominent suppression of NK cell secretory capacity and cytokine signaling pathways. Our study highlights the multifactorial nature of APS-associated placental pathologies, which involve disrupted angiogenesis, cell cycle regulation, and NK cell functionality.
650    _2
$a zvířata $7 D000818
650    _2
$a ženské pohlaví $7 D005260
650    12
$a buňky NK $x imunologie $x metabolismus $7 D007694
650    _2
$a těhotenství $7 D011247
650    12
$a antifosfolipidový syndrom $x imunologie $x patologie $7 D016736
650    12
$a placenta $x metabolismus $x patologie $7 D010920
650    _2
$a myši $7 D051379
650    12
$a modely nemocí na zvířatech $7 D004195
650    12
$a uterus $x patologie $x metabolismus $7 D014599
650    _2
$a transkriptom $7 D059467
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a trofoblasty $x metabolismus $x patologie $x imunologie $7 D014327
650    _2
$a proliferace buněk $7 D049109
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kriegova, E $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Savara, J $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic
700    1_
$a Abroyan, L $u Laboratory of Cell Biology and Virology, Institute of Molecular Biology of NAS RA, Yerevan, 0014, Armenia
700    1_
$a Ghonyan, S $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Biology NAS RA, 7 Hasratyan Str., Yerevan, 0014, Armenia
700    1_
$a Slobodova, Z $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Nesnadna, R $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Manukyan, Gayane $u Laboratory of Molecular and Cellular Immunology, Institute of Molecular Biology NAS RA, 7 Hasratyan Str., Yerevan, 0014, Armenia. gaya.manukyan@gmail.com $u Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic. gaya.manukyan@gmail.com $1 https://orcid.org/0000000175415743
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 14, č. 1 (2024), s. 31163
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39732740 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206103954 $b ABA008
999    __
$a ok $b bmc $g 2263015 $s 1238969
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 1 $d 31163 $e 20241228 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a FNOl, 00098892 $p MH CZ - DRO
GRA    __
$a UP_2024_013. $p IGA LF
GRA    __
$a SCS 21AG-1F072 $p State Committee Science MES RA
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...